School of Medicine
Showing 11-20 of 40 Results
-
Michelle L. James
Associate Professor of Radiology (Molecular Imaging Program at Stanford) and of Neurology and Neurological Sciences (Neurology Research)
Current Research and Scholarly InterestsThe primary aim of my lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.
-
Renesmee Kuo
Affiliate, Neurology Research
BioRenesmee Kuo is an Electrical Engineering PhD candidate at Stanford University supported by NSF GRFP and Stanford Lieberman fellowship. Her research interests lie at the intersection of engineering and medicine. She focuses on validation of preclinical PET imaging tracers and their translation into the clinic for applications in neuroinflammatory diseases (e.g., MS, AD) and cancer (e.g., brain metastasis) in Prof. Michelle James' lab. She graduated from UC Berkeley with a BS in Bioengineering. At Berkeley, she worked in Prof. Steve Conolly's lab on Magnetic Particle Imaging (MPI), focusing on tracking CAR-T cells in immunotherapy using high-resolution MPI tracers. She also explored commercially-available high-resolution MPI tracers for early diagnosis of pulmonary embolisms and cardiovascular disease in preclinical settings.
-
Jin Hyung Lee
Associate Professor of Neurology and Neurological Sciences (Neurology Research), of Neurosurgery and of Bioengineering and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsIn vivo visualization and control of neural circuits
-
Emanuel Manzo-Casio
Life Science Research Professional 1, Neurology Research
Current Role at StanfordLife Science Research Professional
-
Elizabeth Mormino
Associate Professor (Research) of Neurology and Neurological Sciences (Neurology Research)
BioDr. Beth Mormino completed a PhD in Neuroscience at UC Berkeley in the laboratory of Dr. William Jagust, where she performed some of the initial studies applying Amyloid PET with the tracer PIB to clinically normal older individuals. This initial work provided evidence that the pathophysiological processes of Alzheimer’s disease begin years before clinical symptoms and are associated with subtle changes to brain regions critical for memory. During her postdoctoral fellowship with Drs. Reisa Sperling and Keith Johnson at Massachusetts General Hospital she used multimodal imaging techniques to understand longitudinal cognitive changes among individuals classified as preclinical AD. In 2017, Dr. Mormino joined the faculty at Stanford University in the department of Neurology and Neurological Sciences. Her research program focuses on combining imaging and genetics to predict cognitive trajectories over time, and the integration of novel PET scans to better understand human aging and neurodegenerative diseases.